Skip to main content
Screener/Healthcare/Biotechnology

BEAM — Beam Therapeutics Inc.

NASDAQ
$31.25+0.13 (+0.42%)
Mid CapUnder $50HealthcareHigh Beta
$15.60
$36.44
$30.23
$31.72
EPS (TTM)$-0.68
P/E Ratio-39.30
Dividend Yield—
Market Cap$3.03B
Volume817K
Prev Close$31.12
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$94.3M$-0.91——
Q4 '25$114.1M$244.3M$2.3395.0%214.1%
Q3 '25$9.7M-$112.7M$-1.10-1031.9%-1162.4%
Q2 '25$8.5M-$102.3M$-1.00-1102.0%-1208.3%
Q1 '25$7.5M-$109.3M$-1.24-1222.8%-1462.8%
Q4 '24$30.1M-$90.4M$-1.09-237.4%-300.5%
Q3 '24$14.3M-$96.7M$-1.17-560.6%-677.5%
Q2 '24$11.8M-$91.1M$-1.11100.0%-773.5%
Get Your Daily Market Recap